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Prolonged AT1R activation induces 
CaV1.2 channel internalization in 
rat cardiomyocytes
Tamara Hermosilla1, Matías Encina1, Danna Morales1, Cristian Moreno1, Carolina Conejeros1, 
Hilda M. Alfaro-Valdés1, Felipe Lagos-Meza1, Felipe Simon2,4, Christophe Altier3 & Diego 
Varela1,5
The cardiac L-type calcium channel is a multi-subunit complex that requires co-assembling of the 
pore-forming subunit CaV1.2 with auxiliary subunits CaVα2δ and CaVβ. Its traffic has been shown to 
be controlled by these subunits and by the activation of various G-protein coupled receptors (GPCR). 
Here, we explore the consequences of the prolonged activation of angiotensin receptor type 1 (AT1R) 
over CaV1.2 channel trafficking. Bioluminescence Resonance Energy Transfer (BRET) assay between 
β-arrestin and L-type channels in angiotensin II-stimulated cells was used to assess the functional 
consequence of AT1R activation, while immunofluorescence of adult rat cardiomyocytes revealed 
the effects of GPCR activation on CaV1.2 trafficking. Angiotensin II exposure results in β-arrestin1 
recruitment to the channel complex and an apparent loss of CaV1.2 immunostaining at the T-tubules. 
Accordingly, angiotensin II stimulation causes a decrease in L-type current, Ca2+ transients and myocyte 
contractility, together with a faster repolarization phase of action potentials. Our results demonstrate 
that prolonged AT1R activation induces β-arrestin1 recruitment and the subsequent internalization of 
CaV1.2 channels with a half-dose of AngII on the order of 100 nM, suggesting that this effect depends 
on local renin-angiotensin system. This novel AT1R-dependent CaV1.2-trafficking modulation likely 
contributes to angiotensin II-mediated cardiac remodeling.
In mammals, the renin-angiotensin system (RAS) is one of the key factors in the regulation of blood pressure, 
electrolyte balance and cardiac function. Renin catalyzes the conversion of the 14 amino acid propeptide angio-
tensinogen into angiotensin I (AngI), which in turn is cleaved by the angiotensin-converting enzyme (ACE) to 
produce angiotensin II (AngII)1. AngII participates in a series of intracellular signaling cascades via activation of 
its receptors AT1 and AT2, which belong to the superfamily of seven-transmembrane domain G-protein coupled 
receptors (GPCR)2.
Most of the classical actions associated with AngII are dependent on the activation of the AT1 receptor 
(AT1R)3. Binding of AngII results in rapid phosphorylation of the receptor that facilitates β-arrestin recruitment 
induced desensitization and internalization of AT1R4, 5. Thus, activated AT1R is phosphorylated by GPCR kinases 
(GRKs) and subsequently β-arrestin is recruited to the receptor. This receptor/β-arrestin interaction leads to 
receptor desensitization, ending the G protein-dependent signaling by interfering with the coupling between 
the G protein and its receptor. Furthermore, β-arrestin can also bind to components of the clathrin coat, causing 
internalization of activated receptors and target to degradation pathways or recycled back to the cell surface6, 7.
Several recent studies have demonstrated the existence of macromolecular complexes involving GPCRs and 
various ion channels. For example, the dopamine D1 receptor regulates the NMDA receptor through a direct 
interaction6. AT1R co-immunoprecipitates with the non-selective cation channel TRPV47 and with KV4.3, which 
is responsible for the fast transient outward current (Ito) in cardiac myocytes8. Likewise, it has been shown that 
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voltage dependent calcium channels (VDCC) interact with various GPCRs. For instance, N-type Ca2+ channels 
interact with ORL19, GABAb10 and the dopamine D111 and D212 receptors. Interestingly, most of these interac-
tions lead to endocytosis of the channel following activation of the respective receptor8, 9, 11, 13.
In general, VDCCs are protein complexes involving at least three subunits: a CaVα1 subunit that forms the 
channel pore, and CaVα2δ and CaVβ accessory subunits, responsible for trafficking of the channel complex14 to the 
plasma membrane. In cardiomyocytes, LTCC clusters, with specific subcellular localization, have been associated 
with specific functions. Thus, LTCC localized at the T-tubules are mainly responsible for excitation-contraction 
coupling by its association with ryanodine receptor 2 (RyR2) channels, while LTCC localized at the sarcolemma 
are implicated in signaling to the nucleus and regulation of gene transcription15.
Several studies have convincingly shown that AngII modulates L-type currents. However, this modulation 
appears to depend on the cell type and on the species studied. For example, AngII induces an increase of L-type 
currents in smooth muscle cells16 by a PI3Kdependent mechanism17, 18, while in neurons19, 20 and in glomerular 
cells, a decrease in these currents has been observed via a Pertussis toxin sensitive G-protein pathway21.
In cardiomyocytes, the effect on this current after AngII application has been shown to be dependent on the 
species and the patch-clamp configuration used. In hamster22 and guinea pig19 the L-type current is increased, 
while in rabbit23 and cat24 no change is observed in cells studied with conventional whole-cell (WC) recordings, 
in contrast, perforated patch experiments show a potentiation of the L-type current. Finally, in rat25 and human26 
a decrease of the L-type current has been reported using the conventional WC configuration, while the use of 
perforated patch configuration in newborn rat cardiomyocytes shows that the degree of L-type current inhibi-
tion depend on the speed of inactivation of L-type currents27. This evidence together with a growing number of 
reports, establishes a clear link between VDCC and GPCRs, suggesting the existence of a functional association 
between L-type calcium channels and AT1R.
In this work, we demonstrate that AngII stimulation of AT1R causes β-arrestin1 (but not β-arrestin2) recruit-
ment of the L-type calcium channel complex. From a functional stand point, AT1R activation induces inter-
nalization of the T-tubule CaV1.2 population after prolonged exposure to AngII, leading to ~60% reduction of 
endogenous L-type calcium currents, diminished calcium transient amplitude, and reduced action potential 
duration.
Methods
Constructs. cDNA encoding the angiotensin receptor 1, AT1R (NM_000685), was obtained from the 
University of Missouri-Rolla cDNA resource center. cDNAs for calcium channel subunits (GenBank™ accession 
numbers: X15539 (CaV1.2) and AF286488 (CaVα2δ1) were kindly provided by Dr. T. Snutch. CaVβ2b channel 
subunit (AF423193) was cloned as described in Moreno et al.28. The HA epitope inserted into the extracellular 
S5-H5 loop of domain II of CaV1.2 for the HA-tagged CaV1.2 construct is described previously29. CaV1.2-YFP 
and CaVβ1b-YFP were PCR amplified and subcloned into the N1-YFP vector (Clontech) between the NheI and 
BamHI or EcoRI and BamHI restriction sites respectively. β-arrestin-Rluc constructs were kindly provided by Dr. 
R. Ramachandran and AT1R-YFP construct was kindly provided by Dr. LM Luttrell.
AD-293 culture and transfection. Tissue culture of AD-293 cells (Agilent) was performed as recom-
mended by the distributor. Transfection solutions for individual culture dishes (35 mm diameter) contained a 
mixture of cDNA expression vectors (1 μg for each L-type calcium channel subunits (CaVα, CaVβ and CaVα2δ 
subunits), 1 μg of AT1R and 100 ng of β-arrestin-RLuc) and were transfected into cells by the calcium phosphate 
method27. Experiments were conducted at room temperature 2–3 days after transfection.
Isolation of cardiomyocytes. Rats were bred in the Animal Breeding Facility from the Facultad de 
Medicina, Universidad de Chile (Santiago, Chile). All studies were done in accordance and with the approval of 
the Universidad de Chile Institutional Bioethical Committee. Male Sprague Dawley rats (150–200 gr) were anaes-
thetized with ketamine plus xylazine and euthanized by isoflurane overdose before heart excision. Ventricular 
myocytes were isolated by enzymatic digestion in a Langendorff perfusion apparatus. Briefly, the hearts were 
removed, mounted on a Langendorff apparatus and perfused with modified Tyrode solution containing (mM): 
133.5 NaCl, 1.2 NaH2PO4, 4 KCl, 1.8 CaCl2, 1.2 MgSO4, 10 HEPES and 5.5 glucose (pH 7.4 with NaOH) to wash 
out residual blood in the coronary vessels, Ca2+ was replaced with 5 mM EGTA after 3 min wash. Digestion was 
done by perfusion of the heart with modified Tyrode solution containing 25 µM Ca2+, 0.45 mg/ml collagenase 
type II (Worthington) and 0.12 mg/ml protease IV (Sigma-Aldrich) at 37 °C for 7 min, after which the Ca2+ con-
centration was increased to 50 µM for 7 min and further to 400 µM for 5 min. Subsequently, the heart was removed 
from the Langendorff apparatus and the dissociated cardiomyocytes were suspended in 400 µM Ca2+-Tyrode 
solution containing 1 mg/ml BSA, 30 mM taurine and 5 mM pyruvate at room temperature, and the Ca2+ concen-
tration was gradually increased to 1.8 mM. Adult rat cardiomyocytes were cultured on laminin-coated coverslips 
(10 µg/ml) for 2 hr prior to AngII stimulation.
Bioluminescence resonance energy transfer (BRET). AD-293 cells were co-transfected with 
CaV1.2-YFP and β-arrestin-Rluc fusion proteins (+CaVβ and CaVα2δ) or CaVβ-YFP and β-arrestin-Rluc fusion 
proteins (+CaV1.2 and CaVα2δ). After 48 hours, cells were seeded into a 96-well microplate and coelenterazine 
H was added 10 minutes before AngII. CaV1.2 recruitment of β-arrestin was detected every 25 seconds as the 
ratio of the light intensity measured at 535 ± 20 over 475 ± 20 nm using a Tecan fluorometer. BRET signal of cells 
expressing YFP and Rluc was compared with cells overexpressing only Rluc as control. Every BRET experiment 
was performed at a controlled temperature of 23 °C.
Antibody feeding assays. AD-293 cells over-expressing hemagglutinin-epitope (HA-epitope) tagged 
CaV1.2 (+CaVβ and CaVα2δ1) and AT1R were incubated with anti-HA antibody (Roche) for 30 min at 37 °C. 
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Subsequently, cells were stimulated with AngII (1 µM), washed with Hank’s solution and fixed with 4% para-
formaldehyde. Surface-remaining CaV1.2 channels were labeled with a secondary antibody (1:1000) conjugated 
to Alexa Fluor 488 (green, Invitrogen) in PBS. Then, cells were permeabilized with 0.5% triton in PBS (+1% 
BSA) and total CaV1.2 channels were labeled with a secondary antibody (1:1000) conjugated to Alexa Fluor 594 
(red, Invitrogen) in PBS. For image analysis, images were collected on an inverted microscope (Olympus IX-81, 
UPLFLN 40XO 40x/1.3 oil-immersion objective) and acquired using CellR software (Olympus). All image anal-
yses were performed with ImageJ.
To analyze HA-epitope-tagged CaV1.2 internalization, the green signal was converted to a binary image by 
setting the threshold function to the onset of the frequency of staining intensities histogram. With this procedure, 
any green pixel (independent of its original intensity) is set to maximal intensity. To obtain the percentage of 
internalized channels, the resultant binary image was subtracted from the red signal. This new red-signal image 
represents the number of internalized channels and the integrated intensities were normalized by dividing them 
with the integrated intensity of the red signal (that represents the total amount of channels, see Supplementary 
Figure 1).
Immunofluorescence. Adult rat cardiomyocytes were seeded on laminin pretreated coverslips and then 
incubated with AngII (1 µM) in the presence or absence of Losartan (100 nM) (Sigma). Subsequently, cardiomy-
ocytes were washed with PBS and fixed with 4% paraformaldehyde. Cardiomyocytes were then permeabilized 
with 0.02% Triton X-100 in blocking buffer (3% BSA, 5% goat serum in PBS) and incubated for 16 hours with pri-
mary antibodies (Anti-CaV1.2, Alomone #ACC-003, rabbit polyclonal, Anti- βarrestin1/2, Santa Cruz #SC-53781, 
mouse monoclonal, Anti-αActinin, Abcam #AB-9465, mouse monoclonal) before addition of fluorescently labe-
led secondary antibodies and visualization by confocal microscopy. Intracellular signal percentage was calculated 
by integrating the cardiomyocyte surface fluorescence (defined by hand for each image) and subtracting it from 
the total integrated fluorescence. This ensuing signal was then normalized to the total integrated fluorescence.
Colocalization analysis. Intensity Correlation Analysis, performed as described previously29, is based on 
the principle that when two proteins colocalize their staining intensities should vary synchronously30. Briefly, 
the Product of the Differences from the Mean (PDM) of each pixel was calculated and the Intensity Correlation 
Quotient (ICQ) was defined as the ratio of the number of positive PDM pixels to the total pixel numbers. The 
ICQ values are distributed between −0.5 and +0.5 by subtracting 0.5 from this ratio and a dependent staining is 
considered when the ICQ value range between 0 < ICQ ≤ + 0.5.
Calcium Imaging. Plated cardiomyocytes were mounted in a perfusion chamber on the stage of an inverted 
microscope (Olympus IX-81, UPLFLN 40XO 40 x/1.3 oil-immersion objective). Fluorescence was collected using 
a CCD-based imaging system (Olympus DSU) running CellR software (Olympus). Cardiomyocytes were incu-
bated with Fluo-4 (Molecular Probes, 1 µM) as described in ref. 28 and thoroughly washed with external solution 
(mM): 100 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 90 sorbitol, 5 glucose and 10 HEPES (pH 7.4 adjusted with Tris-Base). 
Fluo-4 loaded cardiomyocytes were excited at 480 nm and the fluorescence emission at 510 nm was collected and 
recorded at 12 Hz. For each experiment, signals were recorded and the background intensity subtracted using 
equivalent regions of interest (ROI) outside the cardiomyocytes. Fluo-4 results are expressed as normalized flu-
orescence (F/F0).
Electrophysiology and data analysis. Ca2+ currents were recorded by conventional whole-cell patch 
clamp31. Borosilicate glass pipettes were pulled to 2–4 MΩ resistance and filled with internal solution containing 
(mM): 108 CsCl, 4 MgCl2, 2 CaCl2, 10 EGTA 10 HEPES, 5 MgATP and 0.6 LiGTP (pH 7.2 adjusted with CsOH). 
The bath solution contained (mM): 5 CaCl2, 1 MgCl2, 10 HEPES, 20 TEA-Cl, 10 glucose and 100 NMDG-Cl 
(pH 7.4 adjusted with Tris). Data were acquired at room temperature using an Axopatch 200B amplifier and 
pClamp 10 software (Axon Instruments), low pass-filtered at 5 kHz, and digitized at 10 kHz. Series resistance was 
compensated to 85%. Data analysis, currents fitting and offline leak subtraction were performed in Clampfit 10 
(Axon Instruments), and SigmaPlot 11 (Jandel Scientific). Current-voltage (IV) plots were fitted using a modified 
Boltzmann equation:
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where Erev is the reversal potential, Gmax is the maximum slope conductance, k is the slope factor, and Va the 
half-activation potential.
For action potential (AP) recordings, current-clamp mode was used and APs were elicited by 1 min trains of 
short (2 ms) depolarizing current injections at a frequency of 1 Hz, the average of the last 30 APs was used for 
analysis. Intracellular solution for these recordings was (mM): 120 KCl, 1.5 MgCl2, 0.01 CaCl2, 0.5 EGTA, 10 
HEPES, 5 MgATP and 0.6 LiGTP (pH 7.2 adjusted with KOH). Extracellular solution was: 140 NaCl, 4 KCl, 1 
MgCl2, 2 CaCl2, 10 Glucose and 10 HEPES (pH 7.4 adjusted with NaOH).
Measurement of myocyte shortening. Contractile properties of isolated ventricular myocytes were 
determined by measuring the fractional shortening of single cell cardiomyocyte at room temperature and super-
fused with external solution (mM): 100 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 90 sorbitol, 5 glucose and 10 HEPES (pH 
7.4 adjusted with Tris-Base). Myocytes were field-stimulated with 2 ms pulses at 1 Hz. Cardiomyocyte shortening 
and relengthening was measured on the stage of an inverted microscope (Olympus IX-81, UPLFLN 40XO 40 
x/1.3 oil-immersion objective) using a CCD-based imaging system in which the myocyte motion was collected 
and recorded at 12 Hz and analyzed with ImageJ.
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Statistics. Data are presented as mean ± sem (n). Statistical analysis of the data was performed with 
SigmaPlot 11 (Jandel Scientific) using unpaired Student’s t-test, and was considered significant at P < 0.05. 
One-way ANOVA test was performed for samples exposed to multiple treatments and was considered significant 
at P < 0.05.
Results
In live cells, β-arrestin recruitment to activated AT1R can be measured by the bioluminescence energy transfer 
(BRET) assay32. AngII stimulated AD-293 cells overexpressing β-arrestin1/Rluc or β-arrestin2/Rluc together with 
AT1R/YFP display an increased BRET signal within the first minutes of stimulation (Fig. 1A). Notably, overex-
pression of L-type calcium channels (CaV1.2, CaVβ and CaVα2δ) in the same cells did not change the BRET signal 
(Fig. 1B). Given the fact that BRET can only occur between particles located within ~100 Å from each other, this 
approach enables the study of the AngII-mediated interaction between β-arrestin and CaV1.2 channels in live 
cells. As shown in Supplementary Figure 2, a significant increase in BRET signal is observed upon AngII treat-
ment only in those AD-293 cells expressing β-arrestin1/Rluc, AT1R and a YFP-tagged L-type calcium channel 
(CaV1.2/YFP, CaVβ and CaVα2δ), confirming the close proximity between CaV1.2 complexes and activated AT1R. 
However, C-terminal fusion of YFP to the CaV1.2 α subunit resulted in a relatively small BRET signal. Therefore, 
the experiment was modified to enhance the BRET signal by fusing YFP to the C-terminus of the CaVβ subunit 
(Fig. 1C and D), as CaVβ subunits has been shown to have physiological functions in the absence of CaVα subu-
nits33. Besides the usual negative control (cells without the YFP construct), for these experiments we used cells 
expressing all the constructs, except CaV1.2 (β-arrestin1/Rluc, AT1R, CaVβ/YFP and CaVα2δ). Under this configu-
ration, we detected significant BRET signal changes upon AngII stimulation in those cells expressing β-arrestin1/
Rluc, AT1R and the YFP-tagged LTCC channel subunits (CaV1.2, CaVβ/YFP and CaVα2δ). Those cells lacking 
in CaV1.2 (Fig. 1C and D) or AT1R (not shown) revealed no detectable changes in BRET signal. Interestingly, 
we only observed an increase in BRET signal upon β-arrestin1 (Fig. 1C) but not with β-arrestin2 overexpression 
(Fig. 1D), even though AT1R activation is able to recruit both β-arrestin isoforms (Fig. 1A and B)34. Importantly, 
under our experimental conditions AngII increased the net BRET signal in a concentration-dependent manner 
with an apparent EC50 of 130 ± 50 nM (Fig. 1E, n = 3).
To confirm β-arrestin recruitment to the L-type channel macrocomplex in native cells, adult rat cardiomyo-
cytes were isolated and stimulated with AngII. As expected for CaV1.2 immunostaining, L-type calcium channels 
were observed in a regularly spaced array consistent with the arrangement pattern of T-tubules, as well as surface 
sarcolemmal staining (Fig. 2A and Supplementary Figure 3) which highlights different populations of LTCC 
in cardiomyocytes35. Moreover, immunostaining with a β-arrestin1/2 antibody revealed that in the absence of 
Figure 1. BRET assay between AT1R or CaV1.2 channel and β-arrestins upon AngII stimulation. Time course of 
BRET signal ratio from AD-293 cells transfected with β-arrestin1-RLuc (black circles) or β-arrestin2-RLuc (grey 
circles) plus AT1R-YFP alone (A) or AT1R-YFP plus the L-type calcium channel (CaV1.2, CaVβ and CaVα2δ) 
(B). For negative controls (empty circles), AD-293 cells were transfected without the β-arrestins. Time course 
of BRET signal ratio from AD-293 cells transfected with β-arrestin1-RLuc (C) or β-arrestin2-RLuc (D) plus 
AT1R and a YFP-tagged L-type calcium channel (CaV1.2, CaVβ/YFP and CaVα2δ). For negative controls (empty 
circles), AD-293 cells were transfected without the CaV1.2 subunit. Red lines correspond to the best fit to a 
single rectangular hyperbola. The BRET records are averages of at least five independent experiments (n = 5–8). 
(E) Concentration-response curve of AngII-induced increase in net BRET signal in AD-293 cells transfected 
with β-arrestin1-RLuc plus AT1R and a YFP-tagged L-type calcium channel (CaV1.2, CaVβ/YFP and CaVα2δ), 
the line correspond to the best fit to Hill equation, n = 3. Mean values ± sem are shown.
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agonist, these proteins are distributed along the T-tubules and the plasmalemma with a small cluster found into 
the nucleus (Fig. 2A). A higher amount of β-arrestin1/2 into the T-tubule network was readily observed upon 
addition of AngII (30 min, 1 µM, Fig. 2B). To estimate the degree of colocalization of both proteins at the plasma 
membrane we submitted our data to intensity correlation analysis30, a methodology that assumes that if two 
proteins colocalize, their fluorescence intensities should vary synchronically above the mean fluorescence (see 
methods). Intensity correlation analysis revealed an increase in the mean Intensity Correlation Quotient (ICQ) 
values for CaV1.2 and β-arrestin1/2 upon AngII stimulation (Control: 0.18 ± 0.05, n = 6; AngII: 0.29 ± 0.03, n = 8; 
p < 0.01), which suggests that β-arrestin is mobilized to the site of L-type calcium channel and thus, showing 
enhanced colocalization in acutely isolated rat cardiomyocytes.
Binding of β-arrestin to AT1R results not only in the desensitization of the heteromeric G-protein response, 
but also in the recruitment of various components of the endocytic machinery which promotes internalization 
of the activated receptors from the cell surface36. To explore if binding of β-arrestin resulted in CaV1.2 internali-
zation, we performed antibody feeding experiments (see methods) in AD-293 cells overexpressing an extracellu-
larly tagged CaV1.2 subunit (HA-CaV1.2) and AT1R (Fig. 3). With this protocol, the channels that remained at the 
membrane were immunolabeled in no-permeabilized cells with a 488-green antibody, and the total of those chan-
nels initially localized at the cell surface (internalized plus those that remain at the membrane) immunolabeled 
Figure 2. CaV1.2 and β-arrestin1/2 immunolocalization in adult cardiomyocytes. Representative confocal 
images of CaV1.2 (left) or β-arrestin (middle) immunofluorescences in cardiomyocytes control (A) or treated 
with AngII (1 µM) for 30 min (B), the overlay of individual images is shown on the right panel. All fluorescence 
images were collected at the same gain setting of the microscope. The images are representatives of 6 
independent experiments.
Figure 3. CaV1.2 internalization upon AngII exposure in overexpression system. (A) Confocal images of 
the distribution of HA-epitope-tagged CaV1.2 constructs in AD-293 cells over-expressing CaV1.2 (plus CaVβ 
and CaVα2δ) and AT1R before (top) or after (bottom) treatment with 1 µM AngII (30 min). (B) Summary bar 
graph showing the percentage of channels localized at the plasma membrane, normalized to control condition. 
n = 6. *p < 0.01 compared with control cells. No-perm, cells before permeabilization, representing the CaV1.2 
channels that remain at the plasma membrane; Perm, cell permeabilized that represent the total of channels 
localized at the cell surface at the beginning of the experiment.
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with a 594-red antibody after permeabilized the cells with 0.5% triton, allowing for direct observation and rela-
tive quantification of internalized channels. Our results (Fig. 3) demonstrate a robust loss of CaV1.2 signal at the 
plasma membrane confirming that activation of AT1R indeed promotes the internalization of HA-tagged CaV1.2 
channels.
Likewise, immunostaining of CaV1.2 in rat cardiomyocytes treated with AngII, at different time points, 
revealed a gradual removal of CaV1.2 channel from the T-tubules (Supplementary Figure 3 and Fig. 4). This was 
significant in rat cardiomyocytes treated with AngII (1 µM) for 1 hr (Fig. 4B and D) where predominantly surface 
sarcolemmal staining is observed. In contrast, rat cardiomyocytes simultaneously treated with a specific AT1R 
inhibitor (Losartan, 100 nM, 1 hr) and AngII were undistinguishable from unstimulated cells (99.8 ± 5.5%, n = 4, 
Fig. 4C). These results suggest that only the LTCC population localized at the T-tubules is susceptible to internal-
ization after prolonged AT1R activation.
Control experiments involving α-actinin staining ruled out cardiomyocyte detubulation as an explanation of 
CaV1.2 immunostaining loss after AngII treatment. In brief, an α-actinin antibody was used (Fig. 5) and the spac-
ing between individual T-tubules was assessed by the power spectrum of each image after a fast Fourier transform 
of the signal. Thus, the power spike as a function of the spatial frequency describes the average distance between 
individual Z-discs in the cell (Control: 2.71 ± 0.06 μm; AngII: 2.56 ± 0.11 μm, n = 5; NS), demonstrating that 
α-actinin immunostaining was independent of AngII treatment in our experimental conditions (Fig. 5A and C). 
Likewise, the average distance between CaV1.2 immunostaining bands obtained in control cardiomyocytes 
(2.77 ± 0.03 μm, n = 5; Fig. 5B), or in CaV1.2 immunostaining treated with AngII and losartan (2.67 ± 0.10 μm, 
n = 4; Supplementary Figure 5) were identical, in contrast, the fast Fourier transformation of CaV1.2 immunos-
taining from cardiomyocytes treated with AngII lacks in a peak (Fig. 5D), confirming that normal spacing of 
L-type channels is lost in these cardiomyocytes.
To test if the AT1R activation has functional consequences on CaV1.2, we explored the effect of AngII on 
endogenous L-type calcium currents in adult rat cardiomyocytes. As seen in Fig. 6A, AngII treatment (1 hr, 1 µM) 
induces a decrease of almost 60% of L-type calcium currents (Imax, Control 12.1 ± 1.8 pA/pF, n = 8; Imax, AngII 4.8 ± 0.4 
pA/pF, n = 10; p < 0.05) and a ~10 mv right-shift in the channel voltage dependence of activation as seen in repre-
sentative I-V plots (Fig. 6B). L-type current kinetics were studied by fitting a single exponential to the rising phase 
(activation) or by setting up the residual current after 50 ms of pulse (R50) at different voltages (inactivation). 
We did not observe differences in the activation kinetics (Fig. 6C); however, cardiomyocytes treated with AngII 
displayed a faster inactivation kinetics as indicated by a decreased R50 at all voltage tested (Fig. 6D). In agreement 
Figure 4. CaV1.2 internalization in rat cardiomyocytes treated with AngII. Representative confocal images 
of CaV1.2 immunofluorescence in rat cardiomyocytes, control (A) or treated with AngII (1 µM) for 1 hr 
without (B) or with (C) losartan (100 nM). All fluorescence images were collected at the same gain setting of 
the microscope, nucleus stained with DAPI. (D) Intracellular CaV1.2 immunofluorescence staining intensity 
measurements normalized to control cardiomyocytes (n = 6–10 for each condition) from cardiomyocytes 
treated with AngII (1 µM) for different time points. *p < 0.01 with respect to control.
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with our BRET experiments (Fig. 1E), a concentration dependent response, with an apparent IC50 of ~300 nM was 
observed for L-type current reduction (Fig. 6E, n = 4–10).
A reduction in L-type currents is predicted to have an impact on the magnitude and/or frequency of calcium 
transients and consequently, on cardiomyocyte contraction. To directly investigate this, we evaluated the effect of 
AngII on calcium mobilization and fractional shortening. Intracellular calcium was monitored in rat cardiomy-
ocytes loaded with Fluo-4 and paced extracellularly with a 5 ms pulse at a frequency of 1 Hz. Figure 7 illustrates 
representative intracellular calcium transients recorded in adult rat cardiomyocytes, in control, and treated con-
dition (AngII 1 µM, 1 hr). As shown, calcium transients from rat cardiomyocytes exposed to AngII displayed a 
faster transient decay as compared to control (extracted from single exponential fits to the Ca2+ transient decay; 
Fig. 7D) suggesting that AngII also modifies SERCA activity28. As expected from the reduced L-type calcium 
currents recorded, decreased calcium transient amplitudes are evident in rat cardiomyocytes treated with AngII 
(63.7 ± 1.3% reduction, Fig. 7C, p < 0.05) together with slower time-to-peak. Moreover, fractional shortening 
assessment reveals that in rat cardiomyocytes stimulated at a frequency of 1 Hz and treated with AngII, the frac-
tional shortening was reduced to 30.7 ± 3.7% (Fig. 7E), consistent with the observed reduction of the amplitude 
of calcium transients (Fig. 7C).
Finally, action potentials are the result of the concerted activation of many ion channels, each of which defines 
distinct aspects of its shape. Careful inspection of APs confers an integrative manner to investigate putative 
changes in other voltage-dependent ion channels as a result of AngII prolonged stimulation. Action potential 
duration from ventricular cardiomyocytes was determined as the time where 20%, 50% or 90% of repolarization 
was attained (APD20, APD50 and APD90, respectively). Representative traces of superimposed APs from rat car-
diomyocytes in control and after AngII treatment are displayed in Fig. 8A. Quantification of the repolarization 
phase shows significant differences at APD90 for AngII treated cardiomyocytes (Fig. 8C) suggesting that AngII 
treatment increases potassium currents in these cells. To examine other properties of the elicited action poten-
tials, phase-plane plots were generated by graphing the voltage derivative in time (dV/dt) versus voltage as shown 
in Fig. 8B. AngII treatment does not produce significant alterations in the threshold potential, the depolarization 
slope or the maximal depolarization voltage. Furthermore, the resting membrane potential (RMP) remains unal-
tered after AngII treatment (Fig. 8D and E) which evidences lack of modification of voltage dependent sodium 
currents by the current experimental manipulations.
Figure 5. T-tubule integrity in rat cardiomyocytes treated with AngII. Top: representative confocal images of 
rat ventricular cells stained with an anti-α-actinin antibody (A,C) or an anti-CaV1.2 antibody (B,D). Middle: 
Fluorescence intensity profiles, in arbitrary units, along the longitudinal axis of each cardiomyocytes. Bottom: 
graphs of the fast Fourier transformation of the fluorescence profile. (A,B) control cardiomyocytes; (C,D) 
cardiomyocytes treated with AngII (1 µM) for 1 hr.
www.nature.com/scientificreports/
8SCIentIFIC REPoRTS | 7: 10131  | DOI:10.1038/s41598-017-10474-z
Discussion
GPCR-ion channel macrocomplexes are thought to optimize transductional coupling by preventing the diffusion 
of signaling molecules and by modulating ion channel trafficking, either through regulation of channel surface 
expression or by mediating receptor-dependent internalization. The internalization process is slower than the 
activation of heteromeric G proteins activation (that usually occurs within seconds) and involves β-arrestin bind-
ing to phosphorylated receptors37.
The acute effects of AngII on L-type currents in cardiomyocytes have been extensively studied and appear to 
be species specific20, 24, to depend on the experimental approach used23 and/or on the different signaling mole-
cules expressed27, 38, 39. In contrast, the prolonged effects of AngII on LTCC have received less attention. Prolonged 
AngII stimulation has been shown to increase the amount L-type current in newborn but not in adult mice cardi-
omyocytes40. In HL-1 myocytes, although there is a consensus that prolonged AngII-stimulation also induces an 
increase of L-type current, the reason for this is controversial, with a report showing a main role for β-arrestin240 
and other showing a CREB-dependent de novo expression of CaVα1C41. Moreover, a recent study in canine cardi-
omyocytes suggested a dependence on the transmural muscular layer42, suggesting the same species-specificity 
as for acute AngII stimulation.
Here, we show that in cardiomyocytes from adult rat AngII increases β-arrestin1 recruitment to L-type Ca2+ 
channel and reduces L-type Ca2+ current in a concentration-dependent manner, both processes with an EC50 and 
an IC50 in the order of ~100 nM, respectively (Figs 1E and 6E). This AngII concentration is orders of magnitude 
greater than the concentration of AngII found in plasma (in the order of pM). Nevertheless, it is in good agree-
ment with recent literature showing that prolonged high-doses of AngII produce changes at the single cardiomy-
ocyte level42, 43. This difference suggests that local RAS may play a fundamental role in this process since plasma 
levels of AngII are too low to efficiently modify LTCC levels located at the T-tubules. In fact, recent estimates 
of AngII levels in canine and rat T-tubules are in the order of 100 nM42, 44. Thus, the local RAS at the heart45 
could be important for electrically remodeling cardiomyocytes from different muscle layers, generating regional 
Figure 6. Endogenous L-type currents from cardiomyocytes treated with AngII. (A) Representative whole-
cell endogenous L-type Ca2+ current traces from cardiomyocytes control (upper traces) or treated with 
AngII (1 µM) for 1 hr (lower traces). Currents elicited by a voltage step protocol from –60 mV to + 50 mV in 
10 mV increments, Vh = −80 mV. (B) Summary peak current I/V plots (mean ± sem) obtained from currents 
family as shown in (A), black line represents the best fit to a Bolztman equation (see methods). (C) Voltage-
dependence of the activation time constant (τact, mean ± sem) of L-type Ca2+ currents (D) Graph showing 
the residual current after 50 ms of the depolarization pulse (R50, mean ± sem) versus command voltage of 
L-type Ca2+ currents. Faster inactivation rates result in lower R50 values. (E) Concentration-response curve of 
AngII-induced L-type calcium current reduction in rat cardiomyocytes, the line correspond to the best fit to 
Hill equation, mean values ± sem are shown. In every panel, control rat cardiomyocytes are represented with 
empty circles and rat cardiomyocytes treated with AngII with filled circles. (n = 4–10) *p < 0.01 with respect to 
control.
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heterogeneities in action potential morphology and contractility46. Similarly, our experiments show that pro-
longed stimulation with AngII leads the internalization of the L-type channel population located at the T-tubules 
membrane (Fig. 4).
It is generally agreed that the effects of AngII in the vasculature occur at low levels of this hormone which can 
be used to distinguish them from the effect of AngII in the cardiac system. This can be explained by differences in 
receptor affinity either by post translational modification or by the formation of tissue-specific macrocomplexes 
involving yet unidentified protein partners. However, more work is required to establish a clearer mechanistic 
understanding of this process.
It should be noted that despite differences in the magnitude of the BRET signals obtained with different con-
structs (Fig. 1 and Supplementary Figure 2), the overall trend was consistent with a probable LTCC-β-arrestin1 
interaction. These results are supported by immunostaining data obtained from adult rat cardiomyocytes (Fig. 2). 
We cannot ascertain the underlying reason for the difference in BRET signal amplitude, however some weight 
could be assigned to potentially different orientation of the energy transfer partners as the BRET signal depends 
on the orientation between donor and acceptor.
More interestingly, the BRET experiments reveal a preference for β-arrestin1 recruitment after AT1R activation 
as compared to β-arrestin2. When activated, the AT1R recruits both β-arrestin isoforms (Fig. 1), but ERK sign-
aling pathway activation only occurs when β-arrestin2 but not β-arrestin1 is recruited47. Thus, AT1R interaction 
with CaV1.2 may represent a novel form of GPCR-dependent signaling regulation in which the presence of the 
macromolecular complex controls the specific recruitment of β-arrestin isoforms. Understandably, this hypoth-
esis awaits experimental corroboration.
Functionally, chronic activation of AT1R leads to the internalization of CaV1.2 in a heterologous expression 
system (Fig. 3) and in ventricular rat cardiomyocytes (Fig. 4). Interestingly, internalization of CaV1.2 in ven-
tricular cardiomyocytes appears to be restricted to the population of channels present at the T-tubules known 
to mediate the calcium-induced calcium release process and the plateau phase of action potentials. In turn, the 
plasmalemma channel counterpart known to be involved in gene transcription regulation, seems unchanged 
by chronic stimulation with AngII. This subcellular loci-specific difference could be explained by the selective 
localization of AT1R at the T-tubules48 supporting the idea of the existence of an AT1R/CaV1.2 macrocomplex in 
these cells.
As expected from the loss of CaV1.2 signal at the T-tubule, L-type calcium currents are greatly reduced in 
cardiomyocytes treated with AngII (Fig. 6A). Interestingly, the remaining current display a 10 mV right-shift 
in the I/V curve and a faster inactivation kinetics (Fig. 6B and D), which could be a consequence either of 
Figure 7. Calcium transients in cardiomyocytes treated with AngII. Representative normalized fluorescence 
(Fluo-4) recordings from cardiomyocytes control (A) or treated with AngII (1 µM) for 1 hr (B) and stimulated 
with a 5 ms external stimulus (1 Hz), individual points represent the signal for individual frames, acquire at 
12 Hz. Below each fluorescence recording the respective line-scan images are shown. Bar graph (mean ± sem) 
of average maximal amplitude of electrically evoked Ca2+ transients (C) or time constant of Ca2+ decay (D) 
in cardiomyocytes control or treated with AngII (1 µM) for 1 hr. Data obtained after fitting individual calcium 
transients to a single exponential (n = 30–40, from 4 different cardiomyocytes preparations). *p < 0.01 with 
respect to control. (E) Bar graph (mean ± sem) of fractional shortening. For each bar graph, empty bars 
represents cardiomyocytes control and hatched bar cardiomyocytes treated with AngII (1 µM) for 1 hr. *p < 0.01 
with respect to control.
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post-translational modification of the L-type channels (as oxidation or phosphorylation due to AT1R activation) 
or, as the observed current depends mainly on the LTCC present at the plasmalemma, an indicative that the 
different population of LTCC between the T-tubules and the plasmalemma bears different auxiliary subunits 
that grant them with differential biophysical characteristics. Nevertheless, in accordance with the diminished 
calcium current, the calcium transient amplitudes (Fig. 7C) and cardiomyocyte shortening (Fig. 7E) are simi-
larly decreased. Nonetheless, AngII treatment is not specific for L-type channels, as Ca2+-reuptake is faster in 
AngII-treated cardiomyocytes (Fig. 7D) likely implicating higher activity of SERCA, suggesting that AngII treat-
ment could induce more profound changes in calcium handling than those related to mere modification of the 
L-type current.
Furthermore, action potential measurements (Fig. 8) allowed the monitoring of the coordinated behavior 
of various voltage-dependent ion channels. Despite a relatively low dependence of rat ventricular action poten-
tials on L-type calcium currents, when compared with other species like rabbits or guinea pigs, the fact that 
the voltage threshold (Fig. 8D) and maximal dV/dt (Fig. 8E) were unaltered by AngII treatment clearly indi-
cates that voltage-dependent Na+ channels were unaffected. Likewise, unchanged resting membrane potential in 
AngII-treated cardiomyocytes suggests that “leak” K+ channels are also unmodified. Both observations demon-
strate that AngII-induced CaV1.2 channel internalization does not imply an unselective effect on ion channels. In 
contrast, changes in APD90 suggest that in these tissues, a voltage-dependent K+-channel is activated by chronic 
AT1R stimulation which is yet to be identified.
Concerning the fate of the CaV1.2 channels after prolonged AngII stimulation, those channels could be targeted 
either for degradation or for recycling after its internalization. In fact, a closer look of the plasmalemma-arising 
signal of rat cardiomyocytes treated with AngII (Figs 4 and 5 and Supplementary Figure 4) indicates a more 
continuous signal at the membrane edge when stained with a CaV1.2 antibody, suggesting that at least part of 
the channels originally in the T-tubule network could be re-targeted to the plasmalemma. At the same time, as 
depicted from the signal loss of CaV1.2 total intensity when AngII-treated cardiomyocytes are compared with 
control cardiomyocytes, part of the channels appear to be directed to degradation.
AT1R activation is well known to activate a series of intracellular signaling pathways49, those channels remain-
ing at the membrane are likely to undergo posttranslational modification, such as PKC or CaMKII-dependent 
phosphorylation. Interestingly, these signals are usually associated with activation of the L-type current50, 51, sug-
gesting that after prolonged AngII stimulation the channels in the plasmalemma, usually associated with gene 
transcription, are more active emphasizing the role of the process described here in cardiac remodeling.
Figure 8. Action potentials from cardiomyocytes treated with AngII. (A) Representative action potentials 
waveforms from cardiomyocytes control (solid line) or treated with AngII (1 µM) for 1 hr (dashed line). Action 
potentials were elicited with a short (2 ms) depolarizing current injections (200–400 pA) at a frequency of 
1 Hz. (B) Phase plot of the first derivative of membrane potential (dV/dt) against membrane potential (Vm) 
for the action potentials shown in (A). Control, empty symbols; AngII-treated, filled symbols. (C) Bar graphs 
(mean ± sem) of average action potentials duration (APD) estimated at 20%, 50% and 90% repolarization, 
APD20, APD50 and APD90, respectively. (D) Bar graph (mean ± sem) of maximal action potential amplitudes 
(Overshoot), threshold potentials and mean resting membrane potentials (RMP). (E) Bar graph (mean ± sem) 
of maximum rate of potentials change (dV/dt). For each bar graph, empty bars represents cardiomyocytes 
control and hatched bar cardiomyocytes treated with AngII (1 µM) for 1 hr. (n = 7–10) *p < 0.01 with respect to 
control.
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In summary, we demonstrate a novel signaling pathway involving AT1R activation and LTCC. This 
AngII-dependent intracellular signaling pathway selectively recruits β-arrestin1 after receptor activation, pro-
moting internalization of CaV1.2 channels. In adult rat cardiomyocytes, the AngII driven internalization of 
CaV1.2 occurs almost exclusively at the T-tubules leading to a significant reduction of L-type calcium current and 
calcium transient amplitudes. Functionally, the results presented here provide insights into the mechanisms by 
which prolonged AngII exposure causes cardiac remodeling and could have major implications for understand-
ing the molecular mechanisms controlling the electrical transmural gradient observed in the heart.
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